William Zellmer talks with Kevin Garey and Pablo Okhuysen about strategies for prevention and treatment of recurrent Clostridioides difficile infection.

ASHP Advantage's Engaging the Experts

Strategies for Prevention and Treatment of Recurrent C. difficile Infection

William Zellmer talks with Christine Walko and Shetal Patel about immune checkpoint inhibitors.

Using Immune Checkpoint Inhibitors to Treat Lung Cancer and Melanoma

In Part 3 of this three-part interview on revised USP Chapter , William Zellmer talks with Patricia Kienle, Ashley Duty, and Eric Kastango about practical approaches for attaining compliance.

Revised USP Chapter 797 (Part 3): Practical Approaches to Attaining Compliance

In Part 2 of this three-part interview on revised USP Chapter , William Zellmer talks with Patricia Kienle, Ashley Duty, and Eric Kastango about changes that may be needed to get your facility ready.

Revised USP Chapter 797 (Part 2): Getting Your Facility Ready

In Part 1 of this three-part interview on revised USP Chapter , William Zellmer talks with Patricia Kienle, Ashley Duty, and Eric Kastango about key changes to note.

Revised USP Chapter 797 (Part 1): Overview of Changes

William Zellmer talks with John Petrich and Michael Storey about gene therapies and considerations for integrating them into pharmacy practice.

Integrating Gene Therapies into Pharmacy Practice

Angela Cassano talks with Ryan Forrey about insourcing compounded sterile products and how he addressed the challenges faced at Emory University Hospital Midtown.

Insourcing Sterile i.v. Compounding Service: Emory University Hospital Midtown Profile

Part 2: Future Treatment Options and Roles for Pharmacists in Individualizing Insulin Therapy In Part 2 of this two-part “Engaging the Experts” interview, William Zellmer talks with Curtis L. Triplitt, Susan Cornell, and Joshua J. Neumiller regarding future treatment options for type 2 diabetes and the roles for pharmacists in individualizing insulin therapy. This installment is produced by ASHP Advantage and supported by Novo Nordisk Inc. Faculty: Curtis Triplitt, PharmD, CDE Associate Director, Diabetes Research Center, Texas Diabetes Institute Associate Professor, Department of Medicine, Division of Diabetes University of Texas Health Science Center at San Antonio San Antonio, Texas Susan Cornell, PharmD, CDE, FAPhA, FAADE Associate Director of Experiential Education Associate Professor, Department of Pharmacy Practice Midwestern University Chicago College of Pharmacy Downers Grove, Illinois Joshua Neumiller, PharmD, CDE, FASCP Vice Chair and Associate Professor, Department of Pharmacotherapy Washington State University College of Pharmacy Spokane, Washington C.E. Credits: This activity is not eligible for continuing education credits.

Individualizing Insulin Therapy for Type 2 Diabetes Mellitus (Part 2 of 2)

Part 1: Barriers to Optimizing the Use of Insulin in Managing Type 2 Diabetes In Part 1 of this two-part “Engaging the Experts” interview, William Zellmer talks with Curtis L. Triplitt, Susan Cornell, and Joshua J. Neumiller regarding the barriers to optimizing the use of insulin in managing patients with type 2 diabetes. This installment is produced by ASHP Advantage and supported by Novo Nordisk Inc. Faculty: Curtis Triplitt, PharmD, CDE Associate Director, Diabetes Research Center, Texas Diabetes Institute Associate Professor, Department of Medicine, Division of Diabetes University of Texas Health Science Center at San Antonio San Antonio, Texas Susan Cornell, PharmD, CDE, FAPhA, FAADE Associate Director of Experiential Education Associate Professor, Department of Pharmacy Practice Midwestern University Chicago College of Pharmacy Downers Grove, Illinois Joshua Neumiller, PharmD, CDE, FASCP Vice Chair and Associate Professor, Department of Pharmacotherapy Washington State University College of Pharmacy Spokane, Washington C.E. Credits: This activity is not eligible for continuing education credits.

Individualizing Insulin Therapy for Type 2 Diabetes Mellitus (Part 1 of 2)

In Part 1 of this two-part “Engaging the Experts” interview, William Zellmer talks with Edward Li and James Stevenson regarding the status of biosimilars in the European Union and United States. Faculty: Edward C. Li, Pharm.D., M.P.H., BCOP, Activity Chair Associate Professor Department of Pharmacy Practice University of New England College of Pharmacy Portland, Maine James G. Stevenson, Pharm.D., FASHP Professor, Department of Clinical Pharmacy University of Michigan College of Pharmacy President, Hospital and Health System Services Visante, Inc. Ann Arbor, Michigan C.E. Credits: This activity is not eligible for continuing education credits.

Biosimilars: Current Status in the European Union and United States (Part 1 of 2)

In Part 2 of this two-part “Engaging the Experts” interview, William Zellmer talks with Edward Li and James Stevenson regarding biosimilars, focusing on interchangeability and the integration of biosimilars into the medication-use system. Faculty: Edward C. Li, Pharm.D., M.P.H., BCOP, Activity Chair Associate Professor Department of Pharmacy Practice University of New England College of Pharmacy Portland, Maine James G. Stevenson, Pharm.D., FASHP Professor, Department of Clinical Pharmacy University of Michigan College of Pharmacy President, Hospital and Health System Services Visante, Inc. Ann Arbor, Michigan C.E. Credits: This activity is not eligible for continuing education credits.

Biosimilars: Focus on Interchangeability and Integration into the Medication-use System (Part 2 of 2)

William Zellmer talks with Susan Cornell and Curtis Triplitt about SGLT2 inhibitors, one of the newest classes of oral diabetes medications. With an increasing number of both oral and injectable medications, the faculty explore how SGLT2 inhibitors fit into clinical practice. Faculty: Susan Cornell, Pharm.D., CDE, FAPhA, FAADE, Activity Chair Assistant Director of Experiential Education Associate Professor Department of Pharmacy Practice Midwestern University Chicago College of Pharmacy Downers Grove, Illinois Curtis L. Triplitt, Pharm.D., CDE Associate Director, Diabetes Research Center, Texas Diabetes Institute Associate Professor, Department of Medicine, Division of Diabetes University of Texas Health Science Center at San Antonio San Antonio, Texas C.E. Credits: This activity is not eligible for continuing education credits.

Focus on SGLT2 inhibitors for Diabetes Part 2 of 2

Focus on SGLT2 inhibitors for Diabetes Part 1 of 2

William Zellmer discusses issues related to improving hyponatremia management in hospitalized patients with Joseph Dasta and Gretchen Brophy. They explore how findings from a hyponatremia registry and disease-based medication-use evaluations of hyponatremia can help identify areas of patient care needing improvement. Faculty: Joseph F. Dasta, M.S., MCCM, FCCP, Activity Chair Professor Emeritus The Ohio State University College of Pharmacy Adjunct Professor The University of Texas College of Pharmacy Austin, Texas Gretchen M. Brophy, Pharm.D., BCPS, FCCP, FCCM, FNCS Professor of Pharmacotherapy & Outcomes Science and Neurosurgery Virginia Commonwealth University Medical College of Virginia Campus Richmond, Virginia C.E. Credits: This activity is not eligible for continuing education credits.

Improving Hyponatremia Management Part 2 of 2

Improving Hyponatremia Management Part 1 of 2

Podcast programs produced by ASHP Advantage for health care professionals.

hubhopper

ASHP Advantage's Engaging the Experts

hubhopper